Literature DB >> 16497290

A novel Cripto-related protein reveals an essential role for EGF-CFCs in Nodal signalling in Xenopus embryos.

Karel Dorey1, Caroline S Hill.   

Abstract

The location, timing and intensity of Nodal signalling are all critical for proper patterning of the vertebrate embryo. Genetic evidence from mouse and zebrafish indicates that EGF-CFC family members are essential for Nodal ligands to signal. However, the Xenopus EGF-CFC, FRL1, has been implicated in Wnt signalling and in activation of Erk MAP kinase. Here, we identify two additional Xenopus EGF-CFCs, XCR2 and XCR3. We have focused on the role of XCR1/FRL1 and XCR3, which are both expressed at gastrula stages when Nodal signalling is active. We demonstrate spatial and temporal regulation of XCR1 protein expression, whereas XCR3 appears to be expressed ubiquitously. Using gain and loss of function approaches, we show that XCR1 and XCR3 are required for Nodal-related ligands to signal during early Xenopus development. Moreover, different Nodal-related ligands require different XCRs to signal. When both XCR1 and XCR3 are knocked down, activation of the Nodal intracellular signal transducer, Smad2, is severely inhibited and neither gastrulation nor mesendoderm formation occurs. Together our results indicate that the XCRs are important for modulation of the timing and intensity of Nodal signalling in Xenopus embryos.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16497290     DOI: 10.1016/j.ydbio.2006.01.006

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  28 in total

1.  Unexpected activities of Smad7 in Xenopus mesodermal and neural induction.

Authors:  Irene de Almeida; Ana Rolo; Julie Batut; Caroline Hill; Claudio D Stern; Claudia Linker
Journal:  Mech Dev       Date:  2008-02-12       Impact factor: 1.882

2.  Spatially restricted translation of the xCR1 mRNA in Xenopus embryos.

Authors:  Yan Zhang; Kara D Forinash; Jered McGivern; Brian Fritz; Karel Dorey; Michael D Sheets
Journal:  Mol Cell Biol       Date:  2009-04-13       Impact factor: 4.272

3.  Two highly related regulatory subunits of PP2A exert opposite effects on TGF-beta/Activin/Nodal signalling.

Authors:  Julie Batut; Bernhard Schmierer; Jing Cao; Laurel A Raftery; Caroline S Hill; Michael Howell
Journal:  Development       Date:  2008-09       Impact factor: 6.868

4.  Gtpbp2 is required for BMP signaling and mesoderm patterning in Xenopus embryos.

Authors:  Arif Kirmizitas; William Q Gillis; Haitao Zhu; Gerald H Thomsen
Journal:  Dev Biol       Date:  2014-05-20       Impact factor: 3.582

Review 5.  Nodal morphogens.

Authors:  Alexander F Schier
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-11       Impact factor: 10.005

6.  Dissociation of cardiogenic and postnatal myocardial activities of GATA4.

Authors:  Joseph M Gallagher; Hiba Komati; Emmanuel Roy; Mona Nemer; Branko V Latinkić
Journal:  Mol Cell Biol       Date:  2012-04-02       Impact factor: 4.272

Review 7.  Controlling the Messenger: Regulated Translation of Maternal mRNAs in Xenopus laevis Development.

Authors:  Michael D Sheets; Catherine A Fox; Megan E Dowdle; Susanne Imboden Blaser; Andy Chung; Sookhee Park
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

8.  Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes.

Authors:  Eva Grönroos; Isabel J Kingston; Anassuya Ramachandran; Rebecca A Randall; Pedro Vizán; Caroline S Hill
Journal:  Mol Cell Biol       Date:  2012-05-21       Impact factor: 4.272

9.  APOBEC2, a selective inhibitor of TGFβ signaling, regulates left-right axis specification during early embryogenesis.

Authors:  Alin Vonica; Alessandro Rosa; Brigitte L Arduini; Ali H Brivanlou
Journal:  Dev Biol       Date:  2010-09-27       Impact factor: 3.582

10.  Early activation of FGF and nodal pathways mediates cardiac specification independently of Wnt/beta-catenin signaling.

Authors:  Lee J Samuel; Branko V Latinkić
Journal:  PLoS One       Date:  2009-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.